TP53 and cancer: Thirdly, despite the SEER database containing approximately 28% of population-based cancer registries, other potential predictors such as thyroid function, gene status (BRAF, RET, RAS and P53, etc.), the extent of surgery and angioinvasion were not included in the analysis.